HEARTSCIENCES

HeartSciences is a NASDAQ-listed medical device company that is preparing an FDA De Novo submission for its AI-enabled ECG... HeartSciences seeks to bridge today's "diagnostic gap" in cardiac care by providing effective front-line solutions that assist in the detection of heart disease in at-risk patients. HeartSciences has invested years of R&D focused on advancing the field of electrocardiography through the use of technology to develop new algorithms focused on detecting cardiac conditions not previously available in ECG devices. HeartSciences' MyoVista® Wavelet ECG (wav ECG™) Cardiac Testing Device uses an advanced form of signal processing called continuous wavelet transform (CWT) to extract valuable frequency information from the acquired signal and then analyzes this information using artificial intelligence

Primary location: Southlake United States